Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study

High levels of prevention-effective adherence to HIV pre-exposure prophylaxis (PrEP)

(2021) Benjamin R. Bavinton et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Australian ‘gayborhoods’ and ‘lesborhoods’: a new method for estimating the number and prevalence of adult gay men and lesbian women living in each Australian postcode

(2020) Denton Callander et al.   INTERNATIONAL JOURNAL OF GEOGRAPHICAL INFORMATION SCIENCE

Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care

(2019) Douglas Krakower et al.   Journal of the International AIDS Society

Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017

(2019) Kelsey C Coy et al.   Journal of the International AIDS Society

Cohort profile: l’Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada

(2019) Zoë R Greenwald et al.   BMJ Open

Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics

(2019) Hyman M. Scott et al.   AIDS

PrEP Persistence is a Critical Issue in PrEP Implementation

(2019) Matthew A Spinelli et al.   CLINICAL INFECTIOUS DISEASES

Global implementation of PrEP for HIV prevention: setting expectations for impact

(2019) Maria N Pyra et al.   Journal of the International AIDS Society

Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline

(2019) Lara Esteves Coelho et al.   Lancet HIV

Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial

(2018) Iryna B. Zablotska et al.   BMC PUBLIC HEALTH

Patient Disengagement from an HIV Pre-Exposure Prophylaxis Program in a Sexually Transmitted Disease Clinic

(2018) Julia C. Dombrowski et al.   SEXUALLY TRANSMITTED DISEASES

The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets

(2018) Phillip Keen et al.   Journal of the International AIDS Society

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

(2018) Andrew E Grulich et al.   Lancet HIV

Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report

(2018) Stephanie E Cohen et al.   Lancet HIV

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

(2016) Sheena McCormack et al.   LANCET

Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities

(2016) Philip A Chan et al.   Journal of the International AIDS Society

Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration ProjectPRELUDE

(2016) S Vaccher et al.   BMJ Open

Defining success with HIV pre-exposure prophylaxis

(2015) Jessica E. Haberer et al.   AIDS

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

(2015) Jean-Michel Molina et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

(2010) Robert M. Grant et al.   NEW ENGLAND JOURNAL OF MEDICINE